UnitedHealth Group stock fell early Thursday following a report that the Justice Department is investigating the company for possible criminal Medicare fraud.The news comes only days after the struggling health insurer announced the departure of its CEO Andrew Witty due to personal reasons and suspended its full-year guidance citing high medical costs in its insurance division.

“Given recent price action of UNH shares, losing more than $300bn of its $600bn market-cap in just one month, we believe there is some risk that the name is removed from the Dow,” Mizuho analysts wrote in a note Thursday.

U.S. stock index futures slipped on Thursday as a rally fueled by the U.S.-China tariff truce appeared to ease, while UnitedHealth fell after a report of a DoJ investigation into the health insurer.

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ criminal probe into Medicare fraud.

UnitedHealth Group shares rebounded modestly Wednesday following yesterday's crash, with analysts from UBS, Oppenheimer, and Morgan Stanley leaving their ratings unchanged after the health insurer pulled its outlook and announced its CEO had stepped down.

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

UnitedHealth shares are down about 5% after the Wall Street Journal reported the health insurer was under investigation by the Justice Department for fraud. The stock tu